2025

Angelini Pharma – The Future of Generic Pharmaceuticals: Innovations and Trends

by cyb2025

 

Generic pharmaceuticals have revolutionized the healthcare industry since they entered the market over five decades ago. They have expanded patient access to medications by providing more affordable alternatives to costly brand-name drugs, thereby lowering healthcare costs for consumers and improving public health.

 

ABOUT THE AUTHOR

Carlo Lusso is responsible for CDMO Business Development and Project Portfolio Management for Europe and Asia at Angelini Pharma Fine Chemicals, a business unit of Angelini Pharma S.p.A. With over 30 years of experience in Sales and Business Development, he currently oversees chemical development programs and the technology transfer of in-licensed and custom small molecule APIs and HPAPIs.

Login